Optimizing Early-Stage Oncology: TFS’s Strategic Approach to a Dose Escalation and Expansion Phase I Trial
Discover how a U.S. biotech company partnered with TFS HealthScience to manage a Phase I oncology trial for a new treatment targeting advanced epithelial tumors. The collaboration covered regulatory consulting, site identification, clinical monitoring, and other services to optimize dose escalation and expansion phases. TFS’s expertise streamlined operations, ensuring efficiency and adherence to regulatory standards.
What You’ll Learn:
- How a specialized study team handles seamless trial execution & complex procedures effectively
- The importance of proactive site selection, including a backup site, for enrollment speed & risk reduction
- How prompt data reviews & safety updates allow for timely recruitment & study completion
- The impact of skillful management on slot allocation, patient tracking, & data cleaning
Learn more about our related services and resources:
Connect with Us
Contact us today to discover how TFS can be your strategic CRO partner in clinical development.
Learn More About Our Oncology & Hematology Expertise

Insights from ASCO 2025: Oncology Clinical Trial Trends CROs and Sponsors Need to Know
Insights from ASCO 2025: Oncology Clinical Trial Trends CROs and Sponsors Need to Know

Revolutionizing Oncology Trials: The Power of Immunotherapy and Precision Medicine in Cancer Research
Revolutionizing Oncology Trials: The Power of Immunotherapy and Precision Medicine in Cancer Research

Next-Generation Oncology Research: How CROs Are Accelerating Oncology Drug Development
